Chest pains could last for up to a year from 'long COVID,' new study of 150,000 patients claims

A study from Utah-based Intermountain Healthcare says that those who have previously had COVID-19 could suffer from chest pains for anywhere from six to 12 months after infections. The study does not appear to control for vaccination status and does not mention vaccines in its report.

The study in Salt Lake City looked at approximately 150,000 patients for cardiovascular symptoms, finding that those who tested positive for COVID-19 "had higher rates of chest pain in the six months to a year after the infection."

However, there were no other increases in cardiovascular events.

In addition, the study also states that approximately one in five people who have had COVID-19 report having "long COVID."

"Nearly 19% of U.S. adults who had previously tested positive for COVID-19 report having 'Long COVID,' where they experience signs and symptoms for four weeks or more after the initial phase of infection," the study reads.

The study concludes by stating that those who have been infected by COVID-19 may have health complications "for months, even years, post infection."

At the same time, it was announced that Intermountain Healthcare has joined a medical research initiative, joining a total of 42 health care organizations that will receive funding for upcoming projects. According to KSL.com, health care organizations can receive funding between $500,000 and $5,000,000 from the Health Systems Implementation Initiative.

The initiative is backed by the Patient-Centered Outcomes Research Institute, which is providing an investment of $50 million to fund the initiative. The PCORI describes itself as an "independent, nonprofit research organization that seeks to empower patients and others with actionable information about their health and healthcare choices."

The organization's board of governors consists of over 20 members, all of whom are doctors. It also boasts a diversity-driven strategic plan that "reinforces PCORI’s longstanding commitment to accelerating diversity, equity, and inclusion efforts in all aspects of our activities—through a health equity lens."

In its 2020 annual report, Intermountain Healthcare noted that it receives federal funding specifically to study "long COVID," stating, "Intermountain has leveraged its expertise to launch major initiatives to study Long COVID (persistent symptoms and disability among survivors) with funding from the federal government."

The report also cites working with "the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the U.S. Government’s COVID-19 Therapeutics program."

Intermountain Healthcare has also recently removed its indoor mask requirement for its facilities.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!